Loading...
Market
Financial impact on London Drugs in Q3 2024
5
Resolution / Starting Odds
Profit decline • 33%
Profit increase • 33%
Stable profit • 34%
Quarterly financial reports from London Drugs.
Story
London Drugs Targeted by Ransomware Group LockBit, $25M Demanded in 48 Hours
May 21, 2024, 11:47 PM
London Drugs has been targeted by the ransomware group LockBit, which claims to have stolen data from the company. The group is demanding $25 million within 48 hours to prevent the release of the stolen information. Initial indications confirm that data was indeed stolen during the cybersecurity incident.
View original story
Similar markets
Increase in drug prices • 33%
Decrease in drug availability • 33%
No significant change • 34%
Stock price rises • 33%
Stock price falls • 33%
No significant change • 34%
Significant increase in sales volume • 33%
Moderate increase or stable sales volume • 33%
Decrease in sales volume • 33%
Significant improvement • 25%
Moderate improvement • 25%
No significant change • 25%
Worsened financial performance • 25%
Significant increase • 25%
Moderate increase • 25%
No significant impact • 25%
Decrease due to other factors • 25%
Increase in Earnings • 33%
Decrease in Earnings • 33%
No Significant Change • 34%
Profit decrease • 33%
Profit increase • 33%
No significant change • 34%
Significant Increase (>15%) • 33%
Moderate Increase (5-15%) • 33%
Little to No Change (<5%) • 33%
Increased Profitability • 33%
No Change in Profitability • 33%
Decreased Profitability • 33%
Increase • 33%
Decrease • 33%
Remain stable • 34%